Nanotopology potentiates growth hormone signalling and osteogenesis of mesenchymal stem cells

被引:21
|
作者
Wang, Jessie R. [1 ]
Ahmed, S. Faisal [1 ]
Gadegaard, Nikolaj [2 ]
Meek, R. M. Dominic [4 ]
Dalby, Matthew J. [3 ]
Yarwood, Stephen J. [3 ]
机构
[1] Univ Glasgow, Royal Hosp Sick Children, Dev Endocrinol Res Grp, Glasgow G3 8SJ, Lanark, Scotland
[2] Univ Glasgow, Sch Engn, Glasgow G12 8LT, Lanark, Scotland
[3] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[4] So Gen Hosp, Dept Orthopaed, Glasgow G51 4TF, Lanark, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
Stem cells; Growth hormone; Nanotopology; Osteogenesis; RECEPTOR GENE-EXPRESSION; PROGENITOR CELLS; DIFFERENTIATION; LINEAGE; MICE;
D O I
10.1016/j.ghir.2014.10.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Custom engineered materials can influence the differentiation of human mesenchymal stem cells (MSCs) towards osteoblasts, chondrocytes and adipocytes, through the control of chemistry, stiffness and nanoscale topography. Here we demonstrate that polycaprolactone growth surfaces engineered with disordered (but controlled) 120 nm diameter dots (NSQ50), but not flat surfaces, promote osteogenic conversion of MSCs in the absence of other osteogenic stimuli. Differentiating MSCs on NSQ50 were found to express growth hormone receptors (GH) and stimulation with recombinant human GH (rhGH) further enhanced NSQ50-driven osteogenic conversion of MSCs. This increased osteogenesis coincided with an enhanced ability of GH to activate ERK MAP kinase on NSQ50, but not on flat topology. The importance of ERK for MSC differentiation was demonstrated by using the inhibitor of ERK activation, U0126, which completely suppressed osteogenesis of GH-stimulated MSCs on NSQ50. The ability of GH to activate ERK in MSCs may therefore be a central control mechanism underlying bone development and growth. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 50 条
  • [1] Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability
    Huang, Zhinong
    Ren, Pei-Gen
    Ma, Ting
    Smith, R. Lane
    Goodman, Stuart B.
    [J]. CYTOKINE, 2010, 51 (03) : 305 - 310
  • [2] Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates Osteogenesis
    Seamon, Jesse
    Wang, Xiuli
    Cui, Fuai
    Keller, Tom
    Dighe, Abhijit S.
    Balian, Gary
    Cui, Quanjun
    [J]. BONE MARROW RESEARCH, 2013,
  • [3] Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells
    Xiaoli Ma
    Xueping Zhang
    Yanfei Jia
    Shanshan Zu
    Shuyi Han
    Dongjie Xiao
    Haiji Sun
    Yunshan Wang
    [J]. International Orthopaedics, 2013, 37 : 1399 - 1404
  • [4] Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells
    Ma, Xiaoli
    Zhang, Xueping
    Jia, Yanfei
    Zu, Shanshan
    Han, Shuyi
    Xiao, Dongjie
    Sun, Haiji
    Wang, Yunshan
    [J]. INTERNATIONAL ORTHOPAEDICS, 2013, 37 (07) : 1399 - 1404
  • [5] Osteogenesis of Mesenchymal Stem Cells by Nanoscale Mechanotransduction
    Nikukar, Habib
    Reid, Stuart
    Tsimbouri, P. Monica
    Riehle, Mathis O.
    Curtis, Adam S. G.
    Dalby, Matthew J.
    [J]. ACS NANO, 2013, 7 (03) : 2758 - 2767
  • [6] Mesenchymal stem cells in the treatment of osteogenesis imperfecta
    Lang, Erica
    Semon, Julie A.
    [J]. CELL REGENERATION, 2023, 12 (01)
  • [7] Regulation of adipogenesis and osteogenesis in mesenchymal stem cells by vascular endothelial growth factor A
    Berendsen, A. D.
    Olsen, B. R.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2015, 277 (06) : 674 - 680
  • [8] Mesenchymal stem cells in the treatment of osteogenesis imperfecta
    Erica Lang
    Julie A. Semon
    [J]. Cell Regeneration, 12
  • [9] Interferon β potentiates the therapeutic activity of mesenchymal stem cells
    Vigo, T.
    Laroni, A.
    Matarese, G.
    Uccelli, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 228 - 229
  • [10] Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs
    Manupati, Kanakaraju
    Dhoke, Neha R.
    Debnath, Tanusree
    Yeeravalli, Ragini
    Guguloth, Kalpana
    Saeidpour, Shahrzad
    Chandra, De Utpal
    Debnath, Sudhan
    Das, Amitava
    [J]. FEBS JOURNAL, 2017, 284 (12) : 1830 - 1854